Recent Finacing
Recent Raise
Calporta develops selective small‑molecule TRPML1 agonists to restore lysosomal calcium efflux and trafficking for Niemann‑Pick C and other lysosomal storage disorders; located in San Diego and managed by Avalon Ventures.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor